Robert S. B. Beanlands

Robert S. B. Beanlands's AcademicInfluence.com Rankings

Medical

#2808

World Rank

#3247

Historical Rank

Cardiology

#268

World Rank

#274

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Robert S. B. Beanlands Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Robert S. B. Beanlands's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. (2011) (492)
Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. (2013) (490)
The Use of 18F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario Experience (2012) (430)
F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). (2007) (407)
ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures (2016) (389)
Quantification of myocardial blood flow with 82Rb dynamic PET imaging (2007) (359)
What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? (2006) (345)
Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease?: A systematic review and meta-analysis. (2012) (289)
FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC (2018) (278)
Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. (1993) (275)
Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study). (2005) (272)
Prognostic value of 64-slice cardiac computed tomography severity of coronary artery disease, coronary atherosclerosis, and left ventricular ejection fraction. (2010) (269)
Potential utility of rubidium 82 pet quantification in patients with 3-vessel coronary artery disease (2004) (260)
Projected Valve Area at Normal Flow Rate Improves the Assessment of Stenosis Severity in Patients With Low-Flow, Low-Gradient Aortic Stenosis: The Multicenter TOPAS (Truly or Pseudo-Severe Aortic Stenosis) Study (2006) (255)
Cardiac Sarcoidosis. (2016) (246)
Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions. (2018) (243)
Does quantification of myocardial flow reserve using rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease? (2012) (243)
Effect of Cardiac Resynchronization on Myocardial Efficiency and Regional Oxidative Metabolism (2003) (225)
Evaluation of simulation-based scatter correction for 3-D PET cardiac imaging (1995) (218)
Predictors of Outcomes in Low-Flow, Low-Gradient Aortic Stenosis: Results of the Multicenter TOPAS Study (2008) (208)
Corticosteroid therapy for cardiac sarcoidosis: a systematic review. (2013) (206)
Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry. (2013) (203)
Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability? (1990) (201)
Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging. (1998) (200)
Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function. (2002) (184)
Allograft Vasculopathy: The Achilles' Heel of Heart Transplantation. (2016) (182)
Joint SNMMI–ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring (2017) (174)
Joint SNMMI–ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring (2017) (164)
Potential clinical and economic consequences of noncardiac incidental findings on cardiac computed tomography. (2009) (163)
Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial. (2009) (162)
Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC (2017) (157)
Noninvasive quantification of regional myocardial flow reserve in patients with coronary atherosclerosis using nitrogen-13 ammonia positron emission tomography. Determination of extent of altered vascular reactivity. (1995) (155)
Quantification of myocardial blood flow and flow reserve: Technical aspects (2010) (155)
Diagnostic Accuracy and Impact of Computed Tomographic Coronary Angiography on Utilization of Invasive Coronary Angiography (2009) (153)
Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease). (2012) (152)
Validation of conventional and simplified methods to calculate projected valve area at normal flow rate in patients with low flow, low gradient aortic stenosis: the multicenter TOPAS (True or Pseudo Severe Aortic Stenosis) study. (2010) (150)
The Effects of β1-Blockade on Oxidative Metabolism and the Metabolic Cost of Ventricular Work in Patients With Left Ventricular Dysfunction (2000) (149)
Assessment of diagnostic performance of quantitative flow measurements in normal subjects and patients with angiographically documented coronary artery disease by means of nitrogen-13 ammonia and positron emission tomography. (1998) (148)
Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects. (1994) (146)
B-Type Natriuretic Peptide in Low-Flow, Low-Gradient Aortic Stenosis: Relationship to Hemodynamics and Clinical Outcome: Results From the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) Study (2007) (144)
18F-FDG PET Imaging of Myocardial Viability in an Experienced Center with Access to 18F-FDG and Integration with Clinical Management Teams: The Ottawa-FIVE Substudy of the PARR 2 Trial (2010) (143)
Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC (2017) (141)
Intra- and inter-operator repeatability of myocardial blood flow and myocardial flow reserve measurements using rubidium-82 pet and a highly automated analysis program (2010) (139)
PET myocardial perfusion and metabolism clinical imaging (2009) (138)
Atrioventricular Block as the Initial Manifestation of Cardiac Sarcoidosis in Middle‐Aged Adults (2014) (137)
Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using carbon-11 acetate kinetics in patients with dilated cardiomyopathy. (1993) (132)
Positron emission tomography myocardial perfusion and glucose metabolism imaging (2006) (123)
Assessment of myocardial ischaemia and viability: role of positron emission tomography. (2010) (121)
Multisoftware Reproducibility Study of Stress and Rest Myocardial Blood Flow Assessed with 3D Dynamic PET/CT and a 1-Tissue-Compartment Model of 82Rb Kinetics (2013) (115)
Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment (2011) (110)
CCS/CAR/CANM/CNCS/CanSCMR joint position statement on advanced noninvasive cardiac imaging using positron emission tomography, magnetic resonance imaging and multidetector computed tomographic angiography in the diagnosis and evaluation of ischemic heart disease--executive summary. (2007) (103)
Positron Emission Tomography and Single-Photon Emission Computed Tomography Imaging in the Diagnosis of Cardiac Implantable Electronic Device Infection: A Systematic Review and Meta-Analysis (2017) (101)
Will 3-dimensional PET-CT enable the routine quantification of myocardial blood flow? (2007) (99)
Design of the effect of adaptive servo‐ventilation on survival and cardiovascular hospital admissions in patients with heart failure and sleep apnoea: the ADVENT‐HF trial (2017) (90)
Pet myocardial perfusion and glucose metabolism imaging: Part 2-guidelines for interpretation and reporting (2003) (90)
Stenting versus thrombolysis in acute myocardial infarction trial (STAT). (2001) (89)
Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction. (2001) (88)
Prognostic Value of Rubidium-82 Positron Emission Tomography in Patients After Heart Transplant (2014) (88)
Reduced Myocardial Flow in Heart Failure Patients With Preserved Ejection Fraction (2016) (87)
Prevalence of Cardiac Sarcoidosis in Patients Presenting with Monomorphic Ventricular Tachycardia (2014) (82)
Influence of sex on risk stratification with stress myocardial perfusion Rb-82 positron emission tomography: Results from the PET (Positron Emission Tomography) Prognosis Multicenter Registry. (2013) (80)
The effects of beta(1)-blockade on oxidative metabolism and the metabolic cost of ventricular work in patients with left ventricular dysfunction: A double-blind, placebo-controlled, positron-emission tomography study. (2000) (80)
American Society of Nuclear Cardiology and Society of Nuclear Medicine and Molecular Imaging Joint Position Statement on the Clinical Indications for Myocardial Perfusion PET (2016) (78)
Effects of Short-Term Continuous Positive Airway Pressure on Myocardial Sympathetic Nerve Function and Energetics in Patients With Heart Failure and Obstructive Sleep Apnea: A Randomized Study (2014) (77)
Is There an Association Between Clinical Presentation and the Location and Extent of Myocardial Involvement of Cardiac Sarcoidosis as Assessed by 18F- Fluorodoexyglucose Positron Emission Tomography? (2013) (75)
The effects of continuous positive airway pressure on myocardial energetics in patients with heart failure and obstructive sleep apnea. (2007) (74)
Comparison of 18F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis (2016) (73)
The role of F18-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis (2013) (73)
Usefulness of beta-blocker therapy and outcomes in patients with pulmonary arterial hypertension. (2012) (73)
Isolated cardiac sarcoidosis: establishing the diagnosis with electroanatomic mapping-guided endomyocardial biopsy. (2013) (71)
An automated analysis program for the evaluation of cardiac PET studies: initial results in the detection and localization of coronary artery disease using nitrogen-13-ammonia. (1993) (71)
Interobserver and interstudy variability of myocardial blood flow and flow-reserve measurements with nitrogen 13 ammonia-labeled positron emission tomography (1995) (70)
Short-term repeatability of resting myocardial blood flow measurements using rubidium-82 PET imaging (2012) (70)
Guidance and best practices for nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An Information Statement from ASNC and SNMMI (2020) (65)
Patient motion effects on the quantification of regional myocardial blood flow with dynamic PET imaging. (2016) (64)
Collagen-Based Matrices Improve the Delivery of Transplanted Circulating Progenitor Cells: Development and Demonstration by Ex Vivo Radionuclide Cell Labeling and In Vivo Tracking With Positron-Emission Tomography (2008) (62)
Relation Between Right Ventricular Function and Increased Right Ventricular [18F]Fluorodeoxyglucose Accumulation in Patients With Heart Failure (2011) (62)
Prognostic value of PET myocardial perfusion imaging in obese patients. (2014) (61)
Automated region definition for cardiac nitrogen-13-ammonia PET imaging. (1993) (60)
Treadmill exercise produces larger perfusion defects than dipyridamole stress N-13 ammonia positron emission tomography. (2006) (60)
Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: What Leonardo da Vinci could not see (2012) (60)
Long-Term Follow-Up of Outcomes With F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging–Assisted Management of Patients With Severe Left Ventricular Dysfunction Secondary to Coronary Disease (2014) (60)
A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology (2017) (59)
Sympathetic nervous dysregulation in the absence of systolic left ventricular dysfunction in a rat model of insulin resistance with hyperglycemia (2011) (59)
Prognostic significance of dipyridamole-induced ST depression in patients with normal 82Rb PET myocardial perfusion imaging. (2005) (58)
Cardiac Sarcoidosis multi-center randomized controlled trial (CHASM CS- RCT). (2019) (55)
Detection of serial changes in absolute myocardial perfusion with 82Rb PET. (2000) (55)
Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial (2013) (55)
Redistribution of myocardial blood flow with topical nitroglycerin in patients with coronary artery disease. (1995) (55)
PET Assessment of Epicardial Intimal Disease and Microvascular Dysfunction in Cardiac Allograft Vasculopathy. (2018) (54)
Correction to: Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC (2018) (54)
Application of cardiac molecular imaging using positron emission tomography in evaluation of drug and therapeutics for cardiovascular disorders. (2005) (52)
Characterization of 3-Dimensional PET Systems for Accurate Quantification of Myocardial Blood Flow (2017) (51)
Characterizing the normal range of myocardial blood flow with 82rubidium and 13N-ammonia PET imaging (2013) (50)
Precision-controlled elution of a 82Sr/82Rb generator for cardiac perfusion imaging with positron emission tomography (2007) (50)
Comparison of treadmill exercise versus dipyridamole stress with myocardial perfusion imaging using rubidium-82 positron emission tomography. (2005) (49)
Multimodality Imaging in Evaluation of Cardiovascular Complications in Patients With COVID-19 (2020) (49)
The effects of afterload reduction on myocardial carbon 11-labeled acetate kinetics and noninvasively estimated mechanical efficiency in patients with dilated cardiomyopathy (1994) (49)
Comparison of technetium-99m sestamibi and thallium-201 retention characteristics in canine myocardium. (1992) (48)
Hospitalization Costs of Primary Stenting Versus Thrombolysis in Acute Myocardial Infarction: Cost Analysis of the Canadian STAT Study (2003) (48)
How common is isolated cardiac sarcoidosis? Extra-cardiac and cardiac findings on clinical examination and whole-body 18F-fluorodeoxyglucose positron emission tomography. (2018) (48)
Concomitant treatment with oral L-arginine improves the efficacy of surgical angiogenesis in patients with severe diffuse coronary artery disease: the Endothelial Modulation in Angiogenic Therapy randomized controlled trial. (2008) (47)
Shifts in myocardial fatty acid and glucose metabolism in pulmonary arterial hypertension: a potential mechanism for a maladaptive right ventricular response. (2016) (46)
Phase-III Clinical Trial of Fluorine-18 Flurpiridaz Positron Emission Tomography for Evaluation of Coronary Artery Disease. (2020) (45)
Consistent tracer administration profile improves test–retest repeatability of myocardial blood flow quantification with 82Rb dynamic PET imaging (2016) (45)
Heterogeneity of ventricular function and myocardial oxidative metabolism in nonischemic dilated cardiomyopathy. (1995) (45)
The kinetics of copper-62-PTSM in the normal human heart. (1992) (44)
Presence of Specific 11C-meta-Hydroxyephedrine Retention in Heart, Lung, Pancreas, and Brown Adipose Tissue (2007) (44)
The relationship between myocardial retention of technetium-99m teboroxime and myocardial blood flow. (1992) (44)
Single-Phase CT Aligned to Gated PET for Respiratory Motion Correction in Cardiac PET/CT (2010) (43)
Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA (2013) (43)
Tracking stem cell therapy in the myocardium: applications of positron emission tomography. (2008) (43)
The role of integrin α2 in cell and matrix therapy that improves perfusion, viability and function of infarcted myocardium. (2014) (42)
Accuracy of low-dose rubidium-82 myocardial perfusion imaging for detection of coronary artery disease using 3D PET and normal database interpretation (2012) (41)
Clinical Interpretation Standards and Quality Assurance for the Multicenter PET/CT Trial Rubidium-ARMI (2014) (41)
Evaluation of simulation-based scatter correction for 3D PET cardiac imaging (1995) (41)
F-18-fluorodeoxyglucose PET imaging alters clinical decision making in patients with impaired ventricular function. (1997) (41)
Measuring coronary artery calcification using positron emission tomography-computed tomography attenuation correction images. (2012) (41)
[18F]-Fluorodeoxyglucose PET/CT imaging as a marker of carotid plaque inflammation: Comparison to immunohistology and relationship to acuity of events. (2018) (41)
[18F]-NaF PET/CT Identifies Active Calcification in Carotid Plaque. (2017) (41)
Molecular Imaging for the diagnosis of infective endocarditis: A systematic literature review and meta-analysis. (2018) (40)
Diagnostic and clinical perspectives of fusion imaging in cardiology: is the total greater than the sum of its parts? (2005) (40)
Acute and chronic effects of continuous positive airway pressure therapy on left ventricular systolic and diastolic function in patients with obstructive sleep apnea and congestive heart failure. (2008) (40)
Epicardial adipose tissue thickness as a predictor of impaired microvascular function in patients with non-obstructive coronary artery disease (2013) (37)
Usefulness of intracoronary stenting in acute myocardial infarction. (1996) (37)
Clinical PET Myocardial Perfusion Imaging and Flow Quantification. (2016) (37)
Biodistribution and radiation dosimetry of 82Rb at rest and during peak pharmacological stress in patients referred for myocardial perfusion imaging (2015) (36)
Heterogeneity of regional nitrogen 13-labeled ammonia tracer distribution in the normal human heart: Comparison with rubidium 82 and copper 62-labeled PTSM (1994) (36)
Repeatable Noninvasive Measurement of Mouse Myocardial Glucose Uptake with 18F-FDG: Evaluation of Tracer Kinetics in a Type 1 Diabetes Model (2013) (36)
Alterations of pre- and postsynaptic noradrenergic signaling in a rat model of adriamycin-induced cardiotoxicity (2010) (36)
Quantitative analysis of coronary endothelial function with generator-produced 82Rb PET: comparison with 15O-labelled water PET (2010) (35)
Myocardial blood flow in patients with low-flow, low-gradient aortic stenosis: differences between true and pseudo-severe aortic stenosis. Results from the multicentre TOPAS (Truly or Pseudo-Severe Aortic Stenosis) study (2008) (35)
Early effects of statin therapy on endothelial function and microvascular reactivity in patients with coronary artery disease. (2005) (35)
Manufacture of strontium-82/rubidium-82 generators and quality control of rubidium-82 chloride for myocardial perfusion imaging in patients using positron emission tomography. (1999) (34)
Recent advances in cardiac imaging for patients with heart failure. (2011) (34)
Inter- and Intraobserver Agreement of 18F-FDG PET/CT Image Interpretation in Patients Referred for Assessment of Cardiac Sarcoidosis (2017) (34)
The clinical utility of assessing myocardial blood flow using positron emission tomography (2010) (34)
Effect of lateral wall scar on reverse remodeling with cardiac resynchronization therapy. (2009) (34)
Is septal glucose metabolism altered in patients with left bundle branch block and ischemic cardiomyopathy? (2006) (33)
Greater response to cardiac resynchronization therapy in patients with true complete left bundle branch block: a PREDICT substudy. (2012) (33)
Is ventilatory efficiency (VE/VCO2 slope) associated with right ventricular oxidative metabolism in patients with congestive heart failure ? (2008) (33)
Atherosclerosis imaging and the Canadian Atherosclerosis Imaging Network. (2013) (33)
Can nitrogen-13 ammonia kinetic modeling define myocardial viability independent of fluorine-18 fluorodeoxyglucose? (1997) (33)
Imaging Myocardial Metabolic Remodeling (2010) (33)
Stress perfusion/metabolism imaging: A pilot study for a potential new approach to the diagnosis of coronary disease in women (2000) (32)
Cardiac PET: metabolic and functional imaging of the myocardium. (2013) (32)
Increasing synaptic noradrenaline, serotonin and histamine enhances in vivo binding of phosphodiesterase-4 inhibitor (R)-[11C]rolipram in rat brain, lung and heart. (2006) (31)
Role of plasminogen activator inhibitor-1 in coronary pathophysiology. (2018) (30)
Altered sympathetic nervous system signaling in the diabetic heart: emerging targets for molecular imaging. (2012) (30)
Nuclear Imaging of the Cardiac Sympathetic Nervous System: A Disease-Specific Interpretation in Heart Failure. (2020) (30)
Myocardial viability: it is still alive. (2014) (29)
Effect of exercise training on myocardial blood flow in patients with stable coronary artery disease. (2006) (29)
Identifying high-risk asymptomatic carotid stenosis. (2012) (28)
Gated fluorine 18 fluorodeoxyglucose positron emission tomography: Determination of global and regional left ventricular function and myocardial tissue characterization (2003) (28)
Guidance and best practices for reestablishment of non-emergent care in nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An information statement from ASNC, IAEA, and SNMMI (2020) (28)
Diagnosis and prognosis of coronary artery disease: PET is superior to SPECT: Pro (2010) (27)
Single low-dose CT scan optimized for rest-stress PET attenuation correction and quantification of coronary artery calcium (2015) (27)
Effects of Mitral Valve Surgery on Myocardial Energetics in Patients With Severe Mitral Regurgitation (2010) (27)
Quantification of myocardial flow reserve using positron emission imaging the journey to clinical use. (2009) (26)
Test-retest repeatability of quantitative cardiac 11C-meta-hydroxyephedrine measurements in rats by small animal positron emission tomography. (2013) (25)
Recovery rates of regional sympathetic reinnervation and myocardial blood flow after acute myocardial infarction. (1999) (24)
Naturally occurring R225W mutation of the gene encoding AMP-activated protein kinase (AMPK)γ3 results in increased oxidative capacity and glucose uptake in human primary myotubes (2010) (24)
18F-FDG Cell Labeling May Underestimate Transplanted Cell Homing: More Accurate, Efficient, and Stable Cell Labeling with Hexadecyl-4-[18F]Fluorobenzoate for in Vivo Tracking of Transplanted Human Progenitor Cells by Positron Emission Tomography (2012) (24)
Influence of noninvasive cardiovascular imaging in primary prevention: systematic review and meta-analysis of randomized trials. (2011) (24)
Myocardial perfusion imaging: Lessons learned and work to be done—update (2018) (24)
Novel O-[(11)C]methylated derivatives of candesartan as angiotensin II AT(1) receptor imaging ligands: radiosynthesis and ex vivo evaluation in rats. (2009) (24)
Treating the right patient at the right time: access to specialist consultation and non-invasive testing. (2006) (24)
In vivo selective binding of (R)-[11C]rolipram to phosphodiesterase-4 provides the basis for studying intracellular cAMP signaling in the myocardium and other peripheral tissues. (2007) (24)
Imaging-Guided Selection of Patients With Ischemic Heart Failure for High-Risk Revascularization Improves Identification of Those With the Highest Clinical Benefit (2012) (24)
Appropriate Use Criteria for PET Myocardial Perfusion Imaging (2020) (24)
Prognostic significance of impaired chronotropic response to pharmacologic stress Rb-82 PET (2014) (24)
Does imaging-guided selection of patients with ischemic heart failure for high risk revascularization improve identification of those with the highest clinical benefit?: Imaging-guided selection of patients with ischemic heart failure for high-risk revascularization improves identification of those (2012) (24)
Current and future clinical applications of cardiac positron emission tomography. (2013) (23)
Rates of downstream invasive coronary angiography and revascularization: computed tomographic coronary angiography vs. Tc-99m single photon emission computed tomography. (2012) (23)
Can Functional Testing for Ischemia and Viability Guide Revascularization? (2017) (23)
Imaging Cardiac Sarcoidosis With FLT-PET Compared With FDG/Perfusion-PET: A Prospective Pilot Study. (2019) (23)
Attenuated right ventricular energetics evaluated using 11C-acetate PET in patients with pulmonary hypertension (2014) (21)
Quantitative measurement of sestamibi distribution to detect hidden ischemia made possible by application of Blumgart's method (2011) (21)
The role of nuclear imaging in pulmonary hypertension (2015) (21)
Disability–free survival after coronary artery bypass grafting in women and men with heart failure (2018) (21)
N-Terminal Pro B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T Levels Are Related to the Extent of Hibernating Myocardium in Patients With Ischemic Heart Failure. (2017) (21)
Thermal therapy: a viable adjunct in the treatment of heart failure? (2008) (21)
Usefulness of computed tomographic coronary angiography in patients with acute chest pain with and without high-risk features. (2010) (21)
Cardiac positron emission tomography: current clinical practice. (2009) (21)
PET imaging of a collagen matrix reveals its effective injection and targeted retention in a mouse model of myocardial infarction. (2015) (20)
Defining Quality in Cardiovascular Imaging: A Scientific Statement From the American Heart Association (2017) (20)
Evaluation of outcome and cost-effectiveness using an FDG PET-guided approach to management of patients with coronary disease and severe left ventricular dysfunction (PARR-2): rationale, design, and methods. (2003) (20)
Evaluation of Plasma Adenosine as a Marker of Cardiovascular Risk: Analytical and Biological Considerations (2019) (20)
Guidance and best practices for nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An Information Statement from ASNC and SNMMI (2020) (20)
A fast, simple, and reproducible automated synthesis of [18F]FPyKYNE-c(RGDyK) for αvβ3 receptor positron emission tomography imaging (2012) (19)
Appropriate Use Criteria for Cardiac Computed Tomography: Does Computed Tomography Have Incremental Value in All Appropriate Use Criteria Categories? (2017) (19)
Obesity and the challenges of noninvasive imaging for the detection of coronary artery disease. (2015) (19)
Does FDG PET-assisted management of patients with left ventricular dysfunction improve quality of life? A substudy of the PARR-2 trial. (2012) (19)
Radionuclide Tracers for Myocardial Perfusion Imaging and Blood Flow Quantification. (2016) (19)
Modeling of carbon-11-acetate kinetics by simultaneously fitting data from multiple ROIs coupled by common parameters. (1994) (19)
Use of a column-switching high-performance liquid chromatography method to assess the presence of specific binding of (R)- and (S)-[(11)C]rolipram and their labeled metabolites to the phosphodiesterase-4 enzyme in rat plasma and tissues. (2008) (19)
American Society of Nuclear Cardiology and Society of Nuclear Medicine and Molecular Imaging Joint Position Statement on the Clinical Indications for Myocardial Perfusion PET (2016) (18)
Effects of an endothelin receptor antagonist, Macitentan, on right ventricular substrate utilization and function in a Sugen 5416/hypoxia rat model of severe pulmonary arterial hypertension (2017) (17)
PET of (R)-11C-Rolipram Binding to Phosphodiesterase-4 Is Reproducible and Sensitive to Increased Norepinephrine in the Rat Heart (2011) (17)
Alterations in fatty acid metabolism in adriamycin cardiomyopathy. (1994) (17)
Comparison of Framingham risk score and chest-CT identified coronary artery calcification in breast cancer patients to predict cardiovascular events. (2019) (17)
Reduced CGP12177 binding to cardiac β-adrenoceptors in hyperglycemic high-fat-diet-fed, streptozotocin-induced diabetic rats. (2011) (17)
Evaluation of a novel cardioversion intervention for atrial fibrillation: the Ottawa AF cardioversion protocol. (2018) (17)
Radiosynthesis of N-[(11)C]-methyl-hydroxyfasudil as a new potential PET radiotracer for rho-kinases (ROCKs). (2010) (16)
Reduced septal glucose metabolism predicts response to cardiac resynchronization therapy (2012) (16)
In Vivo Assessment of Myocardial Glucose Uptake by Positron Emission Tomography in Adults With the PRKAG2 Cardiac Syndrome (2009) (16)
Altered myocardial glucose utilization and the reverse mismatch pattern on rubidium-82 perfusion/F-18-FDG PET during the sub-acute phase following reperfusion of acute anterior myocardial infarction (2011) (16)
Granulocyte colony-stimulating factor therapy for stem cell mobilization following anterior wall myocardial infarction: the CAPITAL STEM MI randomized trial (2014) (16)
Clinical performance of Rb-82 myocardial perfusion PET and Tc-99m-based SPECT in patients with extreme obesity (2019) (16)
Reporting of coronary artery calcification on chest CT studies in breast cancer patients at high risk of cancer therapy related cardiac events (2018) (16)
Insulin restores myocardial presynaptic sympathetic neuronal integrity in insulin-resistant diabetic rats (2013) (16)
Cardiac Imaging in the Post-ISCHEMIA Trial Era: A Multisociety Viewpoint. (2020) (16)
Comparison of computed tomographic angiography versus rubidium-82 positron emission tomography for the detection of patients with anatomical coronary artery disease. (2007) (16)
Guidance and best practices for nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An Information Statement from ASNC and SNMMI. (2020) (15)
Scar imaging using multislice computed tomography versus metabolic imaging by F-18 FDG positron emission tomography: a pilot study. (2013) (15)
Reduced oxidative metabolic response in dysfunctional myocardium with preserved glucose metabolism but with impaired contractile reserve. (2004) (15)
IMAGING GUIDELINES FOR NUCLEAR CARDIOLOGY PROCEDURES A Report of The American Society of Nuclear Cardiology Quality Assurance Committee (2006) (15)
Kinetic model-based factor analysis of dynamic sequences for 82-rubidium cardiac positron emission tomography. (2010) (15)
Positron emission tomography in cardiovascular disease. (1996) (15)
Right and left ventricular uptake with Rb-82 PET myocardial perfusion imaging: Markers of left main or 3 vessel disease (2010) (15)
Synthesis and evaluation of the novel 2-[¹⁸F]fluoro-3-propoxy-triazole-pyridine-substituted losartan for imaging AT₁ receptors. (2014) (14)
Preclinical Evaluation of Biopolymer-Delivered Circulating Angiogenic Cells in a Swine Model of Hibernating Myocardium (2013) (14)
Fully Automated Software for Polar-Map Registration and Sampling from PET Images (2006) (14)
The Future of Cardiac Molecular Imaging. (2020) (14)
Guidance and Best Practices for Reestablishment of Non-Emergent Care in Nuclear Cardiology Laboratories During the Coronavirus Disease 2019 (COVID-19) Pandemic: An Information Statement from ASNC, IAEA, and SNMMI (2021) (14)
The Current Role of Viability Imaging to Guide Revascularization and Therapy Decisions in Patients With Heart Failure and Reduced Left Ventricular Function. (2019) (14)
Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review (2021) (14)
[11C]Methyl-losartan as a potential ligand for PET imaging angiotensin II AT1 receptors (2011) (14)
Regional Distribution of Fluorine-18-Flubrobenguane and Carbon-11-Hydroxyephedrine for Cardiac PET Imaging of Sympathetic Innervation. (2020) (13)
Incremental prognostic value of coronary flow reserve assessed with single-photon emission computed tomography (2011) (13)
3D list-mode cardiac PET for simultaneous quantification of myocardial blood flow and ventricular function (2008) (13)
Evaluation of myocardial perfusion using rubidium-82 positron emission tomography after myocardial infarction in patients receiving primary stent implantation or thrombolytic therapy. (2001) (13)
Lessons From the Tc-99m Shortage: Implications of Substituting Tl-201 for Tc-99m Single-Photon Emission Computed Tomography (2013) (13)
Cardiac Sarcoidosis. (2015) (13)
Imaging the failing right ventricle (2012) (13)
Advanced Imaging of Cardiac Sarcoidosis (2015) (13)
IMPROVED ASSESSMENT OF CAD IN OBESE SUBJECTS WITH FLURPIRIDAZ F18 PET MYOCARDIAL PERFUSION IMAGING: A SUBSET ANALYSIS OF THE FLURPIRIDAZ F18 301 PHASE 3 STUDY (2016) (13)
Chronic AMPK activity dysregulation produces myocardial insulin resistance in the human Arg302Gln-PRKAG2 glycogen storage disease mouse model (2013) (12)
Quantification of myocardial blood flow using PET to improve the management of patients with stable ischemic coronary artery disease. (2014) (12)
Elevated level of lecithin:cholesterol acyltransferase (LCAT) is associated with reduced coronary atheroma burden. (2018) (12)
Myocardial viability: whom, what, why, which, and how? (2013) (12)
Prognostic value of treadmill exercise and dobutamine stress positron emission tomography. (2009) (12)
Radionuclide Imaging of Viable Myocardium: Is it Underutilized? (2011) (12)
Analysis of [11C]methyl-candesartan kinetics in the rat kidney for the assessment of angiotensin II type 1 receptor density in vivo with PET. (2013) (12)
Constant-Activity-Rate Infusions for Myocardial Blood Flow Quantification with 82Rb and 3D PET (2006) (12)
Molecular Imaging of Cardiac Sarcoidosis (2018) (12)
Early diabetes treatment does not prevent sympathetic dysinnervation in the streptozotocin diabetic rat heart (2014) (12)
Changes in myocardial oxygen consumption and efficiency with heart failure therapy measured by 11C acetate PET. (1995) (12)
PET imaging of sympathetic innervation with [18F]Flurobenguan vs [11C]mHED in a patient with ischemic cardiomyopathy (2018) (11)
Characterization of 18F-FPyKYNE-Losartan for Imaging AT1 Receptors (2016) (11)
Repeatable and reproducible measurements of myocardial oxidative metabolism, blood flow and external efficiency using 11C-acetate PET (2018) (11)
New effective dose estimates for Rubidium-82 based on dynamic PET/CT imaging in humans (2010) (11)
Validation of multiparametric rubidium-82 PET myocardial blood flow quantification for cardiac allograft vasculopathy surveillance (2020) (11)
Practical guide for interpreting and reporting cardiac PET measurements of myocardial blood flow: an Information Statement from the American Society of Nuclear Cardiology, and the Society of Nuclear Medicine and Molecular Imaging (2021) (11)
PET measurements of cAMP-mediated phosphodiesterase-4 with (R)-[11C]rolipram. (2011) (11)
Uniformity and repeatability of normal resting myocardial blood flow in rats using [13N]-ammonia and small animal PET (2012) (11)
Prognostic value of Rb-82 positron emission tomography myocardial perfusion imaging in coronary artery bypass patients. (2014) (11)
Myocardial kinetics of technetium-99m teboroxime in the presence of postischemic injury, necrosis and low flow reperfusion. (1996) (11)
Coronary artery microvascular dysfunction: Role of sex and arterial load. (2018) (11)
Quantification of regional myocardial blood flow in a canine model of stunned and infarcted myocardium: comparison of rubidium-82 positron emission tomography with microspheres (2010) (11)
Imaging of cardiac sarcoidosis. (2016) (11)
Differentiation of myocardial ischemia and necrosis by technetium 99m glucaric acid kinetics (1997) (11)
Prognostic utility of splenic response ratio in dipyridamole PET myocardial perfusion imaging (2018) (10)
Age, Not Sex, Modifies the Effect of Frailty on Long-term Outcomes After Cardiac Surgery (2020) (10)
Joint SNMMI – ASNC Expert Consensus Document on the Role of 18 F-FDG PET / CT in Cardiac Sarcoid Detection and Therapy Monitoring Writing Group : (2017) (10)
Cardiovascular Nuclear Imaging: Balancing Proven Clinical Value and Potential Radiation Risk (2011) (10)
OUTSMART HF (2020) (10)
ASNC Model Coverage Policy: Cardiac positron emission tomographic imaging (2013) (10)
Randomized Trial Comparing the Effects of Ticagrelor Versus Clopidogrel on Myocardial Perfusion in Patients With Coronary Artery Disease (2017) (10)
Does electrocardiographic Q wave burden predict the extent of scarring or hibernating myocardium as quantified by positron emission tomography? (2005) (10)
SPECT gated blood pool phase analysis of lateral wall motion for prediction of CRT response (2014) (10)
A three-dimensional model-based partial volume correction strategy for gated cardiac mouse PET imaging (2012) (10)
Reduced in vivo phosphodiesterase-4 response to acute noradrenaline challenge in diet-induced obese rats. (2009) (10)
Treatment with enalapril and not diltiazem ameliorated progression of chronic kidney disease in rats, and normalized renal AT1 receptor expression as measured with PET imaging (2017) (9)
Establishing an approach for patients with recent coronary occlusion: Identification of viable myocardium (1999) (9)
American Society of Nuclear Cardiology Practice Guidelines PET Myocardial Glucose Metabolism and Perfusion Imaging Part 1 — Guidelines for Patient Preparation and Data Acquisition (2003) (9)
Computed tomographic coronary angiography for patients with heart failure (CTA-HF): a randomized controlled trial (IMAGE HF Project 1-C) (2013) (9)
Systemic and inflammatory disorders involving the heart: the role of PET imaging. (2016) (9)
Test–retest repeatability of myocardial blood flow and infarct size using 11C-acetate micro-PET imaging in mice (2015) (9)
Competency-Based Medical Education: Do the Cardiac Imaging Training Guidelines Have it Right? (2019) (9)
Intracoronary stenting in the setting of myocardial infarction (1996) (9)
COUNTERPOINT: Should Isolated Cardiac Sarcoidosis Be Considered a Significant Manifestation of Sarcoidosis? No. (2021) (9)
Cell-based vasculogenic studies in preclinical models of chronic myocardial ischaemia and hibernation (2013) (9)
Treatment with corticosteroids is associated with an increase in ventricular arrhythmia burden in patients with clinically manifest cardiac sarcoidosis: Insights from implantable cardioverter‐defibrillator diagnostics (2020) (9)
Metabolic tissue characterization in the failing heart by positron emission tomography. (1994) (9)
Evaluation of [(11)C]methyl-losartan and [(11)C]methyl-EXP3174 for PET imaging of renal AT1receptor in rats. (2015) (9)
FLUORINE-18 LMI1195 POSITRON EMISSION TOMOGRAPHY PROVIDES ACCURATE MEASURE OF CARDIAC SYMPATHETIC INNERVATION COMPARED TO CARBON-11 HYDROXYEPHEDRINE (2018) (9)
Positron Emission Tomography and Single-Photon Emission Computed Tomography Imaging in the Diagnosis of Cardiac Implantable Electronic Device Infection (2017) (8)
Increased myocardial oxygen consumption rates are associated with maladaptive right ventricular remodeling and decreased event-free survival in heart failure patients (2020) (8)
Chapter 19 – Diagnosis and Prognosis in Cardiac Disease Using Cardiac PET Perfusion Imaging (2010) (8)
Variance and covariance of /sup 82/Rb kinetic parameters: computer simulations and dynamic PET studies (2000) (8)
Positron emission tomography: a study of PET test-related anxiety. (2004) (8)
Cardiac applications of positron-emission tomography. (1991) (8)
Optimally Repeatable Kinetic Model Variant for Myocardial Blood Flow Measurements with 82Rb PET (2017) (8)
Prognostic utility of longitudinal quantification of PET myocardial blood flow early post heart transplantation (2020) (8)
Images in cardiovascular medicine. Fluorine-18-labeled deoxyglucose positron emission tomography in the diagnosis and management of aortitis with pulmonary artery involvement. (2005) (8)
Model-based factor analysis of dynamic sequences of cardiac positron emission tomography (2008) (8)
Derivation of Patient-Defined Adverse Cardiovascular and Noncardiovascular Events Through a Modified Delphi Process (2021) (8)
ASNC’s thoughts on the AHA/ACC chest pain guidelines (2021) (8)
Effects of Riociguat on Right Ventricular Remodelling in Chronic Thromboembolic Pulmonary Hypertension Patients: A Prospective Study. (2018) (8)
Prognostic significance of blood pressure response during vasodilator stress Rb-82 positron emission tomography myocardial perfusion imaging (2017) (8)
3D versus 2D dynamic 82Rb myocardial blood flow imaging in a canine model of stunned and infarcted myocardium (2010) (8)
Reproducible quantification of cardiac sympathetic innervation using graphical modeling of carbon-11-meta-hydroxyephedrine kinetics with dynamic PET-CT imaging (2018) (8)
Rubidium-82 generator yield and efficiency for PET perfusion imaging: Comparison of two clinical systems (2020) (8)
Abstract 1353: Short-term Referral Rates to Catheterization After Noninvasive Cardiac Imaging: Results From the Study of Myocardial Perfusion and Coronary Anatomy Imaging Roles in CAD (SPARC) Trial 90 Day Follow-up (2009) (7)
Differential association of diabetes mellitus and female sex with impaired myocardial flow reserve across the spectrum of epicardial coronary disease. (2020) (7)
Saline-push improves rubidium-82 PET image quality (2018) (7)
Detection and severity classification of extracardiac interference in ⁸²Rb PET myocardial perfusion imaging. (2014) (7)
False-positive stress PET–CT imaging in a patient with interstitial injection (2017) (7)
Using coronary calcification to exclude an ischemic etiology for cardiomyopathy: A validation study and systematic review. (2017) (7)
Reliable quantification of myocardial sympathetic innervation and regional denervation using [11C]meta-hydroxyephedrine PET (2019) (7)
Myocardial Viability: From PARR-2 to IMAGE HF - Current Evidence and Future Directions (2018) (7)
Prevalence of patient motion in dynamic PET (2011) (7)
Women Image Wisely: The 3 mSv Challenge for Nuclear Cardiology. (2016) (7)
Sleep apnea in chronic heart failure (2008) (7)
Is There an Age When Myocardial Perfusion Imaging May No Longer Be Prognostically Useful? (2018) (7)
Loss of Cellular Inhibitor of Apoptosis Protein 2 Reduces Atherosclerosis in Atherogenic apoE−/− C57BL/6 Mice on High‐Fat Diet (2013) (7)
82Rb PET imaging of myocardial blood flow—have we achieved the 4 “R”s to support routine use? (2016) (6)
Phantom studies investigating extravascular density imaging for partial volume correction of 3-D PET /sup 18/FDG studies (2002) (6)
The role of nuclear cardiac imaging in risk stratification of sudden cardiac death (2016) (6)
A Clinical Tool to Identify Candidates for Stress-First Myocardial Perfusion Imaging. (2020) (6)
Reporting myocardial flow reserve with PET. Ready or not, here it is! But walk before you fly! (2018) (6)
Analysis of (R)- and (S)-[11C]rolipram Kinetics in Canine Myocardium for the Evaluation of Phosphodiesterase-4 with PET (2012) (6)
Practical Guide for Interpreting and Reporting Cardiac PET Measurements of Myocardial Blood Flow: An Information Statement from the American Society of Nuclear Cardiology, and the Society of Nuclear Medicine and Molecular Imaging (2021) (6)
1094-159 Prognostic value of rubidium-82 perfusion positron emission tomography: Preliminary results from the consecutive 153 patients (2004) (6)
Comparison of myocardial blood flow and flow reserve with dobutamine and dipyridamole stress using rubidium-82 positron emission tomography (2020) (6)
Guidance and Best Practices for Reestablishment of Non-Emergent Care in Nuclear Cardiology Laboratories During the Coronavirus Disease 2019 (COVID-19) Pandemic: An Information Statement from ASNC, IAEA, and SNMMI (2020) (6)
Atrial Arrhythmias in Clinically Manifest Cardiac Sarcoidosis: Incidence, Burden, Predictors, and Outcomes (2020) (6)
The Effects of b1-Blockade on Oxidative Metabolism and the Metabolic Cost of Ventricular Work in Patients With Left Ventricular Dysfunction (2000) (6)
Nuclear perfusion imaging for functional evaluation of patients with known or suspected coronary artery disease: the future is now. (2012) (6)
Guidance and Best Practices for Nuclear Cardiology Laboratories During the COVID-19 Pandemic (2020) (6)
β2-adrenergic stress evaluation of coronary endothelial-dependent vasodilator function in mice using 11C-acetate micro-PET imaging of myocardial blood flow and oxidative metabolism (2014) (6)
Respiratory motion resulting in a pseudo-ischemia pattern on stress PET–CT imaging (2016) (6)
Erratum to: Characterizing the normal range of myocardial blood flow with 82rubidium and 13N-ammonia PET imaging (2013) (6)
Computed tomography coronary angiography for patients with heart failure (CTA-HF): a randomized controlled trial (IMAGE-HF 1C). (2020) (6)
Characterization of 3D PET systems for accurate quantification of myocardial blood flow (2016) (6)
Adenosine as a marker and mediator of cardiovascular homeostasis: a translational perspective. (2019) (5)
Internal validation of myocardial flow reserve PET imaging using stress/rest myocardial activity ratios with Rb-82 and N-13-ammonia (2021) (5)
Effect of proton pump inhibitors on Rubidium-82 gastric uptake using positron emission tomography myocardial perfusion imaging (2019) (5)
Persistent lung inflammation after clinical resolution of community-acquired pneumonia as measured by 18FDG-PET/CT. (2021) (5)
FLT-PET for the assessment of systemic sarcoidosis including cardiac and CNS involvement: a prospective study with comparison to FDG-PET (2020) (5)
Cardiomyocyte-specific deletion of β-catenin protects mouse hearts from ventricular arrhythmias after myocardial infarction (2021) (5)
Assessing myocardial perfusion in suspected coronary artery disease: rationale and design of the second phase 3, open-label multi-center study of flurpiridaz (F-18) injection for positron emission tomography (PET) imaging (2021) (5)
Decreased renal AT1 receptor binding in rats after subtotal nephrectomy: PET study with [18F]FPyKYNE-losartan (2016) (5)
Quantification of myocardial perfusion: What will it take to make it to prime time? (2009) (5)
Treating the right patient at the right time: access to cardiovascular nuclear imaging. (2006) (5)
Routine versus selective cardiac magnetic resonance in non-ischemic heart failure – OUTSMART-HF: study protocol for a randomized controlled trial (IMAGE-HF (heart failure) project 1-B) (2013) (5)
Myocardial glucose utilization and the optimization of F-18-FDG PET imaging in patients with NIDDM, CAD and LV dysfunction (1998) (5)
A minimal factor overlap method for resolving ambiguity in factor analysis of dynamic cardiac PET (2007) (5)
Reproducible Quantification of Regional Sympathetic Denervation with [11C]meta-Hydroxyephedrine PET Imaging (2020) (4)
Optimizing Risk Stratification and Noninvasive Diagnosis of Ischemic Heart Disease in Women. (2018) (4)
Looking for trouble: Reduced myocardial flow reserve following anthracyclines (2019) (4)
Design and Performance of 3D Single Photon Transmission Measurement on a Positron Tomograph with Continuously Rotating Detectors (1996) (4)
Positron Emission Tomography Myocardial Perfusion Imaging for Diagnosis and Risk Stratification in Obese Patients (2014) (4)
Taking PET to heart. (1999) (4)
Cardiovascular imaging: new directions in an evolving landscape. (2013) (4)
PET Assessment of Cardiac Allograft Vasculopathy. (2021) (4)
EVALUATION OF MYOCARDIAL FLOW RESERVE WITH CARDIAC PET IMAGING IN HEART FAILURE PATIENTS WITH PRESERVED EJECTION FRACTION (2014) (4)
Clinical PET Flow Reserve Imaging: Is There Precision to Treat Patients or Populations? (2017) (4)
Quantifying the normal range of myocardial blood flow with /sup 13/N-ammonia PET and tracer kinetic modeling (2005) (4)
Reply: Treatment Nuances in Cardiac Sarcoidosis. (2017) (4)
Patient management guided by viability imaging. (2001) (4)
Exploring Occupational, Recreational, and Environmental Associations in Patients With Clinically Manifest Cardiac Sarcoidosis (2020) (4)
Results from the Multicenter TOPAS Study (2018) (4)
Abstract 18022: Improved Assessment of CAD in Women With Flurpiridaz F-18 PET Myocardial Perfusion Imaging: Results of Subset Analysis of the Flurpiridaz F-18 Phase 3 Study (2015) (3)
Proceedings of the ASNC Cardiac PET Summit, 12 May 2014, Baltimore, MD (2015) (3)
Use of conventional cardiac troponin assay for diagnosis of non-ST-elevation myocardial infarction: ‘The Ottawa Troponin Pathway’ (2020) (3)
Reproducibility of cardiac magnetic resonance imaging in patients referred for the assessment of cardiac sarcoidosis; implications for clinical practice (2020) (3)
Feasibility of exercise rubidium-82 positron emission tomography myocardial perfusion imaging (2003) (3)
Stress Myocardial Perfusion PET Provides Incremental Risk Prediction in Patients with and Patients without Diabetes. (2019) (3)
Radionuclide Imaging in Decision-Making for Coronary Revascularization in Stable Ischemic Heart Disease (2018) (3)
Precision control of eluted activity from a Sr/Rb generator for cardiac positron emission tomography (2004) (3)
The Role of 18F-FDG PET/CT in Cardiac Sarcoidosis (2020) (3)
Heart Teams for Cardiac Imaging: The Right Test at the Right Time for the Right Patient (2019) (3)
Imaging cardiac sarcoidosis with FLT-PET with comparison to FDG-PET: a prospective pilot study (2019) (3)
Abstract 517: FDG PET Imaging Positively Impacts Management Direction and Predicts Outcomes in a Multicenter 'Real World' Setting (2009) (3)
Prognostic value of vasodilator response using rubidium-82 positron emission tomography myocardial perfusion imaging in patients with coronary artery disease (2018) (3)
Comparison of Tc-99m sestamibi perfusion imaging and echocardiography using an arbutamine infusion for the detection of coronary artery disease. (1997) (3)
Late clinical and angiographic follow-up after stenting in evolving and recent myocardial infarction. (1998) (3)
Quantification of Myocardial Oxygen Consumption Using 11C-Acetate (1996) (3)
Reproducible tracer injection profile improves the test-retest repeatability of myocardial blood flow quantification with 82Rb PET (2015) (3)
Serial 18F-Fluorodeoxyglucose Positron Emission Tomography Imaging in a Patient With Giant Cell Myocarditis. (2020) (3)
Quantification of myocardial blood flow in subjects with coronary artery disease with 82Rb dynamic PET imaging (2007) (2)
Role of 18F-Fluorodeoxyglucose/Positron Emission Tomography Imaging to Demonstrate Resolution of Acute Myocarditis. (2017) (2)
STEM CELL MOBILIZATION BY GRANULOCYTE COLONY STIMULATING FACTOR POST MYOCARDIAL INFARCTION TO PROMOTE MYOCYTE REPAIR (2011) (2)
Positron Emission Tomography Imaging of Regional Versus Global Myocardial Sympathetic Activity to Improve Risk Stratification in Patients With Ischemic Cardiomyopathy (2021) (2)
Improvement of ventricular function after atrioventricular junction ablation in a patient with atrial flutter after Mustard's operation. (1996) (2)
Clinical Management of Cardiac Sarcoidosis (2017) (2)
Abstract 325: Impaired Myocardial Flow Reserve Measured Using Rubidium-82 PET Predicts Outcomes in Patients With Suspected Myocardial Ischemia (2009) (2)
Quantification of the normal range of myocardial blood flow and flow reserve with 82rubidium versus 13N-ammonia PET (2007) (2)
Appropriate, quality imaging tests through linkage of payment to guidelines, accreditation and training (2015) (2)
On the roles of reproducibility, ethics, and statistical modeling in medical research (2021) (2)
Editorial Board (2010) (2)
Low-dose 3D PET rubidium ARMI (Alternative Radiopharmaceutical for Myocardial Imaging) multicentre trial standards and quality assurance (2012) (2)
Identification of inflamed aortic plaque in conventional fluorodeoxyglucose-positron emission tomography myocardial viability studies. (2013) (2)
1: The value of PET: Integrating cardiovascular PET into the care continuum (2015) (2)
Correction to: PET imaging of sympathetic innervation with [18F]Flubrobenguane vs [11C]mHED in a patient with ischemic cardiomyopathy (2020) (2)
ASNC Statements of Principles on the Issue of Multimodality Imaging (2021) (2)
Different Characteristics of Disease Detection Between 18F-Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) and Cardiac Magnetic Resonance (CMR) in Patients With Conduction Disease Due to Cardiac Sarcoidosis (2013) (2)
Prognostic value of Rubidium-82 perfusion positron emission tomography in patients referred after SPECT imaging (2005) (2)
The Journey of International Fellows: Have you been to America? (2015) (2)
TRACER KINETICS OF FLUORINE-18 LMI1195 COMPARED TO CARBON-11 HYDROXYEPHEDRINE FOR PET IMAGING OF SYMPATHETIC INNERVATION. (2018) (2)
11C-Acetate for myocardial flow quantification in mice with small animal PET imaging (2010) (2)
Comparison of the myocardial retention of technetium-99M-teboroxime and thallium-201 (1991) (2)
IN THE PRESENCE OF SIGNIFICANT EPICARDIAL CORONARY DISEASE, DIABETES MELLITUS IS FURTHER ASSOCIATED WITH REDUCED MYOCARDIAL FLOW RESERVE (2017) (2)
Postinjection attenuation correction using singles transmission on a positron tomograph without interplane septa (1997) (2)
False-positive 13N-ammonia positron emission tomography perfusion scan caused by misalignment of adjacent lung activity during attenuation correction (2018) (2)
The Cardiac Imaging Fellowship Training Program at the University of Ottawa Heart Institute (2015) (2)
ALTERED ANGIOTENSIN II AT1 RECEPTOR BINDING IN A RENAL HYPERTENSION RAT MODEL IS NORMALIZED WITH ENALAPRIL: PET STUDY WITH [18F]FPYKYNE-LOSARTAN (2015) (2)
516 Cardiac fdg pet results impact decisions and identify patients likely to benefit from revascularization in a multi-center provincial registry (CADRE) (2011) (2)
Comparison of coronary CT angiography versus functional imaging for CABG patients: A resource utilization analysis (2020) (2)
RESEARCH ARTICLE Analysis of (R)- and (S)-( 11 C)rolipram Kinetics in Canine Myocardium for the Evaluation of Phosphodiesterase-4 with PET (2012) (2)
Patient age, gender and hemodynamics are independent predictors of myocardial flow reserve as measured with dipyridamole stress PET perfusion imaging (2014) (2)
ASNC’s global impact: Transforming nuclear cardiology and making the world smaller (2019) (2)
Imaging of the Biomaterial Structure and Function (2015) (2)
Measurement of coronary endothelial function with Rubidium-82 PET - Comparison with oxygen 15-labeled water PET (2008) (2)
Anatomical accuracy & variability in factor analysis of dynamic structures (FADS) with cardiac 18FDG PET imaging (2007) (1)
Prognostic importance of coincidental coronary artery calcification on FDG-PET/CT oncology studies (2020) (1)
Screening patients for primary prophylaxis implantable cardioverter defibrillators: insights into current practices. (2010) (1)
Performance standardization of dynamic range for accurate quantification of myocardial blood flow using 3D PET-CT (2013) (1)
238 Does Short Term Continuous Positive Airway Pressure Alter Myocardial Energetics and Pre-Synaptic Sympathetic Nerve Function in Patients With Heart Failure and Obstructive Sleep Apnea? A Randomized Study (2012) (1)
Anti-inflammatory effect of biologic therapy in patients with psoriatic disease: A prospective cohort FDG PET study. (2023) (1)
Sensitivity and specificity of chest imaging for sarcoidosis screening in patients with cardiac presentations. (2019) (1)
Erratum to: American Society of Nuclear Cardiology and Society of Nuclear Medicine and Molecular Imaging Joint Position Statement on the Clinical Indications for Myocardial Perfusion PET (2017) (1)
190 Immunohistochemical Validation of [18f]-Fluorodeoxyglucose as a Novel Biomarker of Inflamed Vulnerable Carotid Plaque: A Sub-Study of the Canadian Atherosclerosis Imaging Network (CAIN) (2012) (1)
194 Downstream Utilization of Cardiac Investigations in Coronary Artery Bypass Patients: A Comparison of Anatomical Versus Functional Index Imaging With CT Coronary Angiography or Cardiac SPECT (2012) (1)
Kinetics of (R)-[11C] rolipram and (S)-[11C] rolipram In the Dog Heart: Investigation of Four Compartment Models (2006) (1)
Comparison of 3D versus 2D 13N-ammonia PET myocardial perfusion imaging (2010) (1)
Abstract 18193: Stress Myocardial Perfusion Positron Emission Tomography Provides Incremental Risk Prediction in Subjects With and Without Diabetes (2014) (1)
Development of reporter gene imaging techniques for long-term assessment of human circulating angiogenic cells (2015) (1)
Highlights of the 2006 Scientific sessions of the American Society of Nuclear Cardiology: Montreal, Canada, September 7 to 10, 2006. (2007) (1)
135 The Association Between Patterns of Myocardial Involvement and Clinical Presentation in Patients With Cardiac Sarcoidosis As Assessed By FDG-PET (2012) (1)
Directing therapy in patients with severe ventricular dysfunction using FDG PET (1997) (1)
PROGNOSTIC SIGNIFICANCE OF RESTING BLOOD PRESSURE AND BLOOD PRESSURE RESPONSE DURING VASODILATOR STRESS RB-82 POSITRON EMISSION TOMOGRAPHY MYOCARDIAL PERFUSION IMAGING (2015) (1)
Poster Session Wednesday 5 December all day Display * Determinants of left ventricular performance (2012) (1)
Abstract 12921: Incremental Value of Noninvasive Cardiac Imaging in Risk Prediction: Results from the SPARC Study (2010) (1)
Reply: Using and Interpreting 18F-FDG PET/CT Images in Patients Referred for Assessment of Cardiac Sarcoidosis: The Devil Is in the Details (2017) (1)
Positron molecular imaging, an in vivo glimpse of the genome. (2007) (1)
LONG TERM FOLLOW UP OF OUTCOMES WITH F-18-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY IMAGING- ASSISTED MANAGEMENT OF PATIENTS WITH SEVERE LEFT VENTRICULAR DYSFUNCTION SECONDARY TO CORONARY DISEASE: 5-YEAR FOLLOW-UP OF THE PARR-2 RANDOMIZED CONTROLLED TRIAL (2014) (1)
Abstract 17612: Is Glucose Corrected [18f]-fluorodeoxyglucose Uptake in Human Carotid Plaque Associated with the Extent of Inflammation on Immunohistology? A Sub-Study of the Canadian Atherosclerosis Imaging Network (CAIN) (2012) (1)
In vivo evaluation of [11C]methyl-Losartan as a selective AT1R radioligand in rats (2010) (1)
Test-retest repeatability of myocardial blood flow measurements in mice using 11C-acetate and small animal PET imaging (2013) (1)
Abstract 18880: Inflammation Imaged With [18F]-FDG PET/CTA is Related to 3D Ultrasound Phenotypes of High-risk Carotid Plaque: Sub-study of the Canadian Atherosclerosis Imaging Network (CAIN-2) (2015) (1)
New rubidium-82 generator efficiency improves over time (2018) (1)
[11C]meta-hydroxyephedrine PET evaluation in experimental pulmonary arterial hypertension: Effects of carvedilol of right ventricular sympathetic function (2021) (1)
Accuracy of low-dose rubidium-82 myocardial perfusion imaging for detection of CAD using 3D PET-CT normal database limits: Initial results from the ARMI trial (2012) (1)
Anti-inflammatory effect of rosuvastatin in patients with HIV infection: An FDG-PET pilot study (2021) (1)
Abstract 16967: Preclinical Evaluation of Biopolymer-Delivered Endothelial Progenitor Cells in Hibernating Myocardium (2011) (1)
Abstract 17207: The Role Of Ciap2 In Atherosclerotic Lesion Developmen (2010) (1)
Myocardial fatty acid and glucose metabolism in patients with pulmonary arterial hypertension (2014) (1)
The use of 18F-FDG PET imaging in diagnosis of cardiac sarcoid: A systematic review (2010) (1)
Abstract 17358: Prognostic Value of Splenic Response Ratio in Rubidium-82 Positron Emission Tomography Myocardial Perfusion Imaging (2016) (1)
SYSTEMATIC REVIEW OF THE DIAGNOSTIC UTILITY OF RUBIDIUM-82 POSITRON EMISSION TOMOGRAPHY PERFUSION IMAGING IN COMPARISON TO SINGLE PHOTON EMISSION TOMOGRAPHY (2012) (1)
16.22: Discordance Between Framingham Risk Score and Coronary Artery Plaque Burden (2007) (1)
Role of PET in Diagnosis and Risk Assessment in Patients with Known or Suspected CAD (2015) (1)
Lesion contrast recovery for partial-volume averaging: Quantitative correction or qualitative enhancement? (2018) (1)
Quantification of coronary artery calcium using low-dose PET-CT attenuation correction scan (2013) (1)
THE EFFECT OF CRT THERAPY ON RV FUNCTION IN PATIENTS WITH SEVERE LV DYSFUNCTION: A MATCHED CONTROL STUDY (2013) (1)
Characterization of 3 D PET systems for accurate quantification of myocardial blood (2016) (1)
Reduced rate of diagnostic coronary imaging following Rubidium PET vs Thallium SPECT, as alternatives to Technetium SPECT myocardial perfusion imaging (2013) (1)
Imaging in CTO: Should you look before you open? (2020) (1)
Vascular Inflammation During and After Community-Acquired Pneumonia as Measured by 18F-FDG-PET/CT Imaging. (2022) (1)
Cardiac Sympathetic Positron Emission Tomography Imaging with Meta-[18F]Fluorobenzylguanidine is Sensitive to Uptake-1 in Rats. (2021) (1)
USING 3D ELECTROANATOMICAL MAPPING TO GUIDE ENDOMYOCARDIAL BIOPSY FOR CARDIAC SARCOIDOSIS (2014) (1)
FLT-PET for the assessment of sarcoidosis including cardiac and CNS involvement: Comparison to FDG-PET (2019) (1)
Noninvasive quantification of myocardial perfusion using positron emission tomography (1992) (1)
Does Quantification of [11C]meta-hydroxyephedrine and [13N]ammonia Kinetics Improve Risk Stratification in Ischemic Cardiomyopathy (2021) (1)
Prevalence of extra-cardiac interference in 82Rb PET myocardial perfusion imaging (2013) (1)
Abstract 3192: Identification of High Risk Patients with Ischemic Cardiomyopathy using FDG PET (2007) (1)
A revised effective dose estimate for the PET perfusion tracer Rb-82 (2008) (1)
Abstracts of Original Contributions ASNC2020 The 25th Annual Scientific Session of the American Society of Nuclear Cardiology (2020) (1)
013 In patients with normal perfusion imaging, is there a relationship between calcium score and myocardial flow reserve? (2011) (1)
mRNA COVID-19 Vaccination and Development of CMR-confirmed Myopericarditis (2021) (1)
Is there a role for imaging heart teams? Looking forward together! (2019) (1)
How to Write a Good Myocardial Perfusion Imaging Report: Current North American Reports (2016) (1)
Imaging Assessment of myocardial ischaemia and viability : role of positron emission tomography (2010) (1)
[11C]Methyl-candesartan displays binding specificity for angiotensin II AT1 receptors (2009) (1)
What does the future hold for nuclear cardiology? (2019) (1)
Cardiovascular drug development using radiopharmaceuticals. (2009) (1)
Listmode dynamic-static-gated imaging of myocardial flow reserve, perfusion uniformity, and ejection fraction reserve with Rb-82 PET (2008) (1)
A novel method to measure vascular inflammation by [18F]fluorodeoxyglucose PET/computed tomography scanning of the aorta. (2019) (1)
PET imaging standards for the Ontario Provincial Registry of Cardiac Viability Imaging with FDG PET (CADRE) (2009) (1)
VALIDATION OF AN ANATOMIC MEASURE OF CORONARY STENOSIS WITH COMPUTED TOMOGRAPHY ANGIOGRAPHY TO PREDICT HEMODYNAMIC SIGNIFICANCE OF DISEASE DEFINED BY FLOW QUANTIFICATION USING RUBIDIUM-82 POSITRON EMISSION TOMOGRAPHY (2010) (1)
[18F] FLURPIRIDAZ PET MYOCARDIAL FLOW RESERVE QUANTIFICATION USING PHARMACOLOGIC AND TREADMILL EXERCISE STRESS TESTING (2018) (1)
243Quality assurance metrics for routine clinical PET rubidium-82 myocardial blood flow quantification (2019) (1)
(477) - Increased Right Ventricular Sympathetic Activity and Oxygen Consumption in Patients with Right Ventricular Dysfunction (2017) (0)
High-resolution PET demonstrates extensive ischemia/fibrosis mismatch in a patient with hypertrophic cardiomyopathy: the power of multimodality image fusion (2022) (0)
Is fatty acid metabolism altered in adriamycin cardiomyopathy (1991) (0)
THE ASSESSMENT OF MECHANICAL RV DYSSYNCHRONY USING PHASE ANALYSIS OF RNV IMAGING IN SUBJECTS WITH NORMAL AND SEVERELY REDUCED LV FUNCTION (2013) (0)
Sympathetic stimulation to evaluate the coronary endothelial function in mice with 11C-acetate (2012) (0)
The Relationship Between Right Ventricular Function and Increased Right Ventricular [ 18 F ] Fluorodeoxyglucose Accumulation in Patients with Heart Failure (2010) (0)
for cardiac perfusion imaging with positron emission tomography (2007) (0)
Integrin α2β1 Is Required for Synergistic Effect of Cells and Matrix Therapy in Improving the Perfusion, Viability and Function of Infarcted Hearts (2013) (0)
Evaluation of Lung Glucose Uptake with Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/CT in Patients with Pulmonary Arterial Hypertension and Pulmonary Hypertension Due to Left Heart Disease. (2015) (0)
Agreement between patient and heart motion during dynamic cardiac PET imaging (2014) (0)
Abstract 18167: Improved Stem Cell Tracking after Intramyocardial Injection by Hexadecyl-4-[18F]fluorobenzoate Labeling with Positron Emission Tomography (2010) (0)
604 Pre-clinical evaluation of biopolymer-delivered endothelial progenitor cells in hibernating myocardium (2011) (0)
CHARACTERIZATION OF ATRIAL SYMPATHETIC FUNCTION IN PATIENTS WITH HEART FAILURE USING C-11 HED PET (2016) (0)
Older patients with cardiovascular disease: A new frontier for nuclear cardiology? (2019) (0)
Noninvasive PET Flow Reserve Imaging to Direct Optimal Therapies for Myocardial Ischemia (2016) (0)
Presence of Speciﬁc 11 C- meta- Hydroxyephedrine Retention in Heart, Lung, Pancreas, and Brown Adipose Tissue (2007) (0)
Myocardial efficiency reserve predicts the deterioration in exercise capacity over time in patients with heart failure (2005) (0)
Abstract 13236: The Use of 18f-fdg to Detect Changes in Atherosclerotic Lesions in Atherogenic Apoe -/- Mice (2011) (0)
577 The role of fluorodeoxyglucose positron emission tomography guided management in improving quality of life amongst patients with ischemic left ventricular dysfunction (2011) (0)
Abstract 19815: Staging Atherosclerotic Disease and Vessel Remodeling with [18F]-Sodium Fluoride, a Novel Biomarker of Active Calcification: Sub-study of the Canadian Atherosclerosis Imaging Network (CAIN-2) (2014) (0)
LO60: Diagnostic utility of creatine kinase in the diagnosis and management of non-ST elevation myocardial infarction (2018) (0)
713 [11C]Methyl-EXP3174 as a Potential Radioligand for Imaging AT1Receptor With Pet (2012) (0)
Subtotal nephrectomy rat model leads to a decrease in renal AT1R binding of [11C] methyl-candesartan PET (2012) (0)
487 The use of 18F-FDG to detect changes in atherosclerotic lesions in atherogenic apoE −/− mice (2011) (0)
β-Adrenoceptor Expression is Reduced in Zucker Diabetic Fatty Rats and Increased in Euglycemic Zucker Obese Rats After 6 Weeks of Sustained Hyperglycemia (2013) (0)
EVALUATION OF PULMONARY GLUCOSE METABOLISM WITH FDG-PET/CT IN PATIENTS WITH PULMONARY ARTERY HYPERTENSION AND PULMONARY HYPERTENSION DUE TO LEFT HEART DISEASE (2014) (0)
Relationship between the standardized uptake value (SUV) and left ventricular ejection fraction (LVEF) in patients with cardiac sarcoidosis (CS) (2013) (0)
COMPARISON OF DIAGNOSTIC PERFORMANCE OF CT MYOCARDIAL PERFUSION WITH Rb-82 PET MYOCARDIAL PERFUSION IMAGING (2014) (0)
MULTIPARAMETRIC RUBIDIUM-82 POSITRON EMISSION TOMOGRAPHY MYOCARDIAL BLOOD FLOW QUANTIFICATION ASSESSMENT OF CARDIAC ALLOGRAFT VASCULOPATHY (2018) (0)
Quantification of myocardial blood flow in rat myocardium with N-13-ammonia and a new microPET scanner (2008) (0)
710 Reduced Left Atrial Metabolic Activity in Patients With Atrial Fibrillation is Associated With Worse LV Function (2012) (0)
Static CT myocardial perfusion imaging: image quality, artifacts including distribution and diagnostic performance compared to 82Rb PET (2022) (0)
Negative Association of Smoking History With Clinically Manifest Cardiac Sarcoidosis: A Case-Control Study (2022) (0)
Clinical performance of a prototype rubidium-82 elution system for PET myocardial perfusion imaging (2015) (0)
Reproducibility and repeatability of cardiac 11C-Hydroxyephedrine PET sympathetic nervous system imaging and kinetics (2018) (0)
FRS-049 Effects of Continuous Positive Airway Pressure on Myocardial Energetics in Heart Failure and Obstructive Sleep Apnea Using ^ Cacetate PET(Therapeutic Strategies for Cardiovascular Disease, The 71st Annual Scientific Meeting of the Japanese Circulation Society) (2007) (0)
The Effects of &bgr;1-Blockade on Oxidative Metabolism and the Metabolic Cost of Ventricular Work in Patients With Left Ventricular Dysfunction: A Double-Blind, Placebo-Controlled, Positron-Emission Tomography Study (2000) (0)
Equivalent Regional Distribution of Fluorine-18 Flurobenguan and Carbon-11 Hydroxyephedrine for PET Imaging of Sympathetic Innervation. (2019) (0)
CORONARY ARTERY MICROVASCULAR DYSFUNCTION: ROLE OF SEX AND ARTERIAL LOAD (2015) (0)
578 Pet imaging standards and quality assurance for the rubidium ARMI (alternative radiopharmaceutical for myocardial imaging) multicentre trial (2011) (0)
ANTI-INFLAMMATORY EFFECT OF BIOLOGIC THERAPY IN PATIENTS WITH PSORIATIC DISEASE COMPARED WITH TREATMENT WITH NON-BIOLOGIC DMARDS: A PROSPECTIVE COHORT FDG-PET STUDY (2021) (0)
Reproducibility of left ventricular ejection fractions using PET blood flow and metabolism tracers: Rb-82, N-13-ammonia and F-18-FDG (2013) (0)
1094-158 Altered myocardial perfusion with fatty meal ingestion in normal volunteers (2004) (0)
P302Routine PET imaging of myocardial flow reserve using simple activity ratios - internal validation using Rb-82-chloride and N-13-ammonia (2019) (0)
Normal population variability and test-retest reproducibility of mouse heart FDG uptake and SUV with the Siemens Inveon (2010) (0)
INHIBITION OF FATTY ACID OXIDATION IS ASSOCIATED WITH IMPROVED RIGHT VENTRICULAR FUNCTION AND METABOLISM IN TWO RAT MODELS OF PULMONARY ARTERIAL HYPERTENSION (2017) (0)
Response to Poitrasson-Rivière and Murthy (2021) (0)
Evaluation of sympathetic function with PET 11C-hydroxyephedrine (HED) and ammonia (13N-NH3) in a canine pacing model of atrial fibrillation (2018) (0)
CHAPTER 2 Positron Emission Tomography Instrumentation (0)
Letter by Birnie et al Regarding Article, "Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis: Implications for the Diagnosis of Isolated Cardiac Sarcoidosis". (2019) (0)
Prognostic Value of Rubidium-82 Positron Emission Tomography for Evaluation of Patients Following Cardiac Transplantation (2013) (0)
Data-driven motion correction rescues interpretation of rubidium PET scan with extreme breathing artifacts (2021) (0)
In Vivo and Ex Vivo Imaging Demonstrate Effective Injection and Retention of a Collagen Matrix in a Mouse Model of Myocardial Infarction (2013) (0)
Evaluating presynaptic sympathetic nervous function in adriamycin-induced cardiotoxicity in rats (2008) (0)
Sex-specific temporal trends in ambulatory heart failure incidence, mortality and hospitalisation in Ontario, Canada from 1994 to 2013: a population-based cohort study (2020) (0)
SENSITIVITY AND SPECIFICITY OF CHEST IMAGING FOR SCREENING OF SARCOIDOSIS IN PATIENTS WITH CARDIAC PRESENTATIONS: INSIGHTS FROM THE CHASM-CS REGISTRY (2016) (0)
Nuclear Cardiology, the Future is Now! (2019) (0)
Implications of the Discrepancy in Ejection Fraction Reporting Between Echocardiography and Radionuclide Angiography in a “Real-World” Tertiary Care Heart Function Clinic (2013) (0)
Abstract 17970: Atrial Fibrillation is Associated With Increased Atrial Metabolic Activity on FDG/PET Imaging in Patients With Ischemic Cardiomyopathy (2015) (0)
PROSPECTIVE COHORT EVALUATION OF BETA-BLOCKER USE IN CLINICAL AND FUNCTIONAL PARAMETERS AND MORTALITY IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (2011) (0)
Small animal PET imaging of myocardial PDE4 with (R)-[11C]rolipram in rats (2010) (0)
PET Flow Quantification: An Arbitrator in Patients With Ischemic Cardiomyopathy?: The Jury Is Still Out. (2020) (0)
292 Investigating the role of rho kinase in cardiac hypertrophy using a novel pet radiotracer (2011) (0)
Poster Session 3: Tuesday 5 May 2015, 08:30-12:30Room: Poster Area. (2015) (0)
OR 01 Impact of revascularization versus medical therapies on left ventricular functional recovery in patients with reduced ejection fraction and coronary artery disease : A systematic review & network meta-analysis (2018) (0)
Correction to: Does quantification of [11C]meta-hydroxyephedrine and [13N]ammonia kinetics improve risk stratification in ischemic cardiomyopathy (2021) (0)
PATTERN OF EXTRA CARDIAC INVOLVEMENT IN PATIENTS PRESENTING WITH ACUTE CARDIAC SARCOIDOSIS (2016) (0)
Myocardial perfusion imaging: Lessons learned and work to be done-Update By Editors of J Nuc Cardiol (2019) (0)
Comparison of N-13-amonia and O-15-water in the measurement of myocardial blood flow by positron emission tomography (1991) (0)
Abstract 19207: Altered Cardiac Energetics and Impaired Sympathetic Activity in Patients With Right Ventricular Failure (2017) (0)
Abstract 13158: Development of Reporter Gene Techniques for Long-Term Assessment of Transplanted Human Circulating Progenitor Cells with Positron Emission Tomography (2011) (0)
Abstract 14320: Determination of the Impact of Short Term Continuous Positive Airway Pressure on Myocardial Energetics in a Randomized Study of Patients with Chronic Stable Heart Failure and Obstructive Sleep Apnea (2011) (0)
Cardiac Imaging of Infiltrative Cardiomyopathies (2015) (0)
[18F]-SODIUM FLUORIDE IS A NOVEL BIOMARKER OF ACTIVE CALCIFICATION AND POSITIVE PLAQUE REMODELING: A SUB-STUDY OF THE CANADIAN ATHEROSCLEROSIS IMAGING NETWORK (CAIN-2) (2014) (0)
Effect of reperfusion following myocardial infarction on measurement of myocardial perfusion with RB-82 and PET imaging (1997) (0)
Intra- and inter-operator repeatability of myocardial blood flow and myocardial flow reserve measurements using Rubdium-82 PET (2010) (0)
Abstracts of Original Contributions ASNC2013 The 18th Annual Scientific Session of the American Society of Nuclear Cardiology (2013) (0)
Abstract 15942: Low Agreement of 18F-Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) and Cardiac Magnetic Resonance (CMR) in Patients With Conduction Disease Due to Cardiac Sarcoidosis (2013) (0)
170 Quantitative Scar Imaging Using Multislice Computed Tomography Versus Metabolic Imaging By F-18 FDG Positron Emission Tomography: A Proof Of Concept Study (2012) (0)
3D carotid reconstructions: imaging, pathology, algorithms and pipelines (2015) (0)
721 Assessment of Aortic Plaque Inflammation and Its Relationship With Aortic Dilatation by FDG PET/CT Hybrid Imaging (2012) (0)
Radiosynthesis of a novel [F-18]fluoropyridine derivative of the angiotensin II AT(1) antagonist losartan (2011) (0)
Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk. (2022) (0)
Beta Receptor Blockade Fails to Recover Ventricular Function Despite Increased Pre-Synaptic Sympathetic Nervous System Function in Experimental Pulmonary Arterial Hypertension (2019) (0)
Normal variability and test-retest reproducibility of myocardial blood flow measurements in mice using C-11 acetate and small animal PET imaging (2009) (0)
POSITRON EMISSION TOMOGRAPHY ASSESSMENT OF CORONARY MICROVASCULAR DYSFUNCTION IN PATIENTS WITH ANGINA AND NON-OBSTRUCTIVE CORONARY ARTERY DISEASE (2023) (0)
Abstract 327: Reduced Myocardial Flow Reserve Quantified With Rubidium-82 PET is an Independent Predictor of Three Vessel Coronary Artery Disease (2009) (0)
4.14: Computed tomographic coronary angiography and Framingham risk factor scores: Further support for direct screening for atherosclerosis (2008) (0)
Abstract 395: Myocardial Perfusion Imaging With a New Cadmium Zinc Telluride Based SPECT Camera (2009) (0)
Abstract 10987: Is There an Association Between Myocardial Flow Reserve as Measured on Rubidium-82 Positron Emission Tomography and Allograft Rejection in Patients Following Cardiac Transplantation? (2013) (0)
ASSOCIATION OF BASELINE MODEST ALCOHOL CONSUMPTION AND CORONARY MICROVASCULAR DYSFUNCTION IN THE CARDIOVASCULAR INFLAMMATION REDUCTION TRIAL (CIRT-CFR) (2023) (0)
Metabolic activity of the left and right atria are differentially altered in patients with atrial fibrillation and LV dysfunction (2022) (0)
A Matched Control Study to Assess the Effect of Crt on Rv Function in Patients With Severe Lv Dysfunction (2013) (0)
Discordant Microvascular and Epicardial Disease in Cardiac Allograft Vasculopathy. (2020) (0)
Abstract 21325: Is Retention of the Presynaptic Sympathetic Nerve Function Probe, [11C] Hydroxyephedrine, Related to Myocardial Blood Flow in Non-Ischemic Cardiomyopathy? (2010) (0)
Abstract 20739: Compared to C-Reactive Protein and Homocysteine, [18F]-FDG PET/CTA Uptake is Directly Related to Intraplaque Inflammatory Burden of High-Risk Carotid Plaque: A Sub-Study of the Canadian Atherosclerosis Imaging Network (CAIN-2) (2016) (0)
193 Does Rubidium-82 PET Have Superior Diagnostic Accuracy Compared to An Optimized SPECT System? A Systematic Review and Meta-Analysis (2012) (0)
Net retention of 82Rb versus 13N-ammonia with dynamic PET imaging (2008) (0)
Non-invasive diagnosis of vasospastic angina (2022) (0)
FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: Joint procedural recommendation of the EANM, SNMMI, the PET Interest Group (PIG), and endorsed by the ASNC Writing group*: (2018) (0)
Low-dose rubidium-82 3D PET versus thallium-201 SPECT myocardial perfusion imaging for detection of coronary artery disease (2016) (0)
Right Ventricle Glucose Metabolism and Pressure Overload in Patients with Pulmonary Arterial Hypertension (2011) (0)
Abstract 13031: A Randomized Trial Comparing the Effects of Ticagrelor versus Clopidogrel on Myocardial Perfusion in Patients With Coronary Artery Disease (2015) (0)
[18F]FPYKYNE- Losartan AT1 Receptor Binding Is Reduced in Chronic Kidney Disease Rat Model With Pet Imaging (2013) (0)
Abstract 11091: Failure of Right Ventricular Adaptation to Pressure Overload Due to a Profound Deficiency in Adenylate Kinase 1 and Impaired Ventricular Energetics (2021) (0)
Quantification of Myocardial Blood Flow Using Rubidium-82 PET (2010) (0)
Applications in Nonischemic Heart Disease and Heart Failure (1996) (0)
EVALUATION OF RIGHT VENTRICULAR METABOLISM IN RIGHT HEART FAILURE ASSOCIATED WITH PULMONARY ARTERIAL HYPERTENSION (2014) (0)
PET imaging of AT1R with [18F]FPyKYNE-Losartan: Dosimetry studies in rats (2015) (0)
Abstract P396: Noncanonical Wnt5a Increases QT Interval And Susceptibility To Ventricular Arrhythmias (2021) (0)
Quantitative analysis of coronary endothelial function with generator-produced rubidium- 82 PET - Comparison with oxygen 15-labeled water PET- (2017) (0)
Canadian Association of Neuropathologists L'Association Canadienne des Neuropathologistes (2012) (0)
EXPLORING ENVIRONMENTAL AND OCCUPATIONAL EXPOSURES IN PATIENTS WITH CARDIAC SARCOIDOSIS: A CASE-CONTROL STUDY (2019) (0)
Abstract 311: CRP is Probably Not Causal in Atherosclerosis (2014) (0)
Chapter 36 – Use of Cardiac Imaging in the Evaluation of Heart Failure (2011) (0)
Abstract 1775: Prognostic Value of Exercise and Dobutamine Positron Emission Tomography (2007) (0)
1094-160 Prognostic significance of dipyridamole-induced ST-segment depression in patients with normal rubidium-82 positron emission tomography perfusion images (2004) (0)
Characterization of patients with preserved and reduced myocardial flow reserve measured using Rubidium-82 PET (2009) (0)
The Novel Endothelin Receptor Antagonist, Macitentan, Improved Right Ventricular Function and Normalized Glucose Uptake in a Sugen5416/hypoxia Rat Model of Severe Pulmonary Artery Hypertension (2014) (0)
Native anomalous left coronary artery from the pulmonary artery in an adult: Evidence of impaired coronary flow reserve by rubidium-82 positron emission tomography quantification. (2006) (0)
Reduced [18F]FPyKYNE-losartan uptake confirms impaired renal AT1 receptors in type 1 diabetic (OVE26) mouse (2015) (0)
TEST-RETEST REPEATABILITY AND INTRA- AND INTER-OPERATOR REPRODUCIBILITY OF [11C]ACETATE PET OXIDATIVE METABOLISM AND MEASUREMENTS OF MYOCARDIAL EFFICIENCY (2017) (0)
Abstract 16734: Partial Inhibition of Fatty Acid Oxidation Improves Oxidative Metabolism and Right Ventricular Function in Pulmonary Arterial Hypertension Rats (2017) (0)
Short-term repeatability of absolute myocardial blood flow using rubidium-82 PET (2012) (0)
671 Increased Cardiac AT1R in the post ischemic myocardium in a transient left anterior descending artery ligation/reperfusion rat model (2011) (0)
THE ACCURACCY OF PET AND SPECT IMAGING IN THE DIAGNOSIS OF IMPLANTABLE ELECTRONIC CARDIAC DEVICE INFECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS (2016) (0)
PET and SPECT Evaluation of Viable Dysfunctional Myocardium (2021) (0)
Abstract 20105: Sympathetic Nervous Dysregulation Without Systolic Dysfunction in a Rat Model of Insulin Resistance with Sustained Hyperglycemia (2010) (0)
CLINICAL PERFORMANCE OF RB82 MYOCARDIAL PERFUSION PET AND TC-99M SPECT IN PATIENTS WITH EXTREME OBESITY (BMI ≥ 40) (2015) (0)
Evaluation of heart transplant rejection and ventricular function with technetium-99m antimyosin imaging (1996) (0)
Cardiac Resynchronization and Myocardial Oxidative Metabolism (2003) (0)
Abstract 19374: A Collagen Matrix for Endothelial Progenitor Cell Therapy Improves Myocardial Function through Enhanced Cell Retention and Phenotype in a Mouse Model of Myocardial Infarction (2010) (0)
Reply: Noninvasive Measurement of Mouse Myocardial Glucose Uptake with 18F-FDG (2014) (0)
Reduced metabolic reserve in both right and left ventricles in patients with heart failure (2002) (0)
DOES FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY GUIDED MANAGEMENT IMPROVE QUALITY OF LIFE IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION? A QUALITY OF LIFE SUBSTUDY OF THE PARR2 TRIAL (2011) (0)
Posters display III clinical outcome and PET (2005) (0)
24.18: Right and left ventricular tracer uptake ratio with dipyridamole Rb-82 PET myocardial perfusion imaging in identifying patients with left main or 3-vessel CAD (2008) (0)
EXERCISE FLOW RESERVE IMAGING WITH 18F-FLURPIRIDAZ PET RULES OUT HIGH-RISK OBSTRUCTIVE CORONARY ARTERY DISEASE (2023) (0)
Imaging standards and quality assurance for the PET Rubidium ARMI (Alternative Radiopharmaceutical for Myocardial Imaging) multicentre trial (2011) (0)
Transient ischemic dilation with dipyridamole RB-82 PET imaging for detection of multivessel CAD in patients with normal perfusion, scar or ischemia (2004) (0)
IMPLICATIONS OF THE DISCREPANCY IN EJECTION FRACTION REPORTING BETWEEN ECHOCARDIOGRAPHY AND RADIONUCLIDE ANGIOGRAPHY IN A TERTIARY CARE HEART FUNCTION CLINIC (2014) (0)
595 Evaluation of [18F]PyKYNE-losartan in rats using pet imaging (2011) (0)
Abstract 2062: Predictors Of Outcome In Low Flow, Low Gradient Aortic Stenosis. Result Of The Multicenter Topas Study (2007) (0)
182 An Integrin-Linked Kinase Mechanism is Associated with Improved Perfusion, Viability, and Function of Infarcted Myocardium Following Cell-Matrix Therapy (2011) (0)
Vienna-Mayo Contemporary Clinical Cardiology 2006-September 14-16, 2006, Vienna (Abstracts) (2016) (0)
Coronary Flow Reserve, Inflammation, and Myocardial Strain (2022) (0)
A Spline Model for Rv Registration from Cardiac Pet Images (2017) (0)
Characterizing coronary endothelial function with C-11-acetate microPET (2013) (0)
PROGNOSTIC VALUE OF MAGNETIC RESONANCE IMAGING IN CLINICALLY SILENT CARDIAC SARCOIDOSIS: A META-ANALYSIS (2016) (0)
Abstract 18028: [18F]-fluorodeoxyglucose is a Stronger Correlate of Intraplaque Inflammatory Burden in Human Carotid Plaque Than C-Reactive Protein: A Sub-Study of the Canadian Atherosclerosis Imaging Network (CAIN) (2013) (0)
(918) – Rubidium 82 Positron Emission Tomography in Cardiac Allograft Vasculopathy (2017) (0)
Phantom studies investigating extravascular density imaging for partial volume correction of 3D PET /sup 18/FDG studies (2002) (0)
OTTAWA CRP STUDY AFTER TIA AND VASCULAR EVENTS (OCTAVE) (2019) (0)
An imaging performance standard for MBF quantification with 3D PET (2010) (0)
Evidence for Actively Inflamed Bilateral Carotid Plaque in Patients With Advanced Atherosclerosis, Insight From [18F]-Fluorodeoxyglucose Imaging: A Sub-Study of the Canadian Atherosclerosis Imaging Network (CAIN) (2013) (0)
Training/Practice Contemporary Issues in Cardiology Practice Obesity and the Challenges of Noninvasive Imaging for the Detection of Coronary Artery Disease (2015) (0)
THE EFFECTS OF A NOVEL ENDOTHELIN RECEPTOR ANTAGONIST, MACITENTAN, ON RIGHT VENTRICULAR SUBSTRATE UTILIZATION AND FUNCTION IN A SUGEN5416/HYPOXIA RAT MODEL OF SEVERE PULMONARY ARTERY HYPERTENSION (2014) (0)
Abstracts of Original Contributions ASNC2017 The 22nd Annual Scientific Session of the American Society of Nuclear Cardiology (2017) (0)
ASSESSMENT OF CARDIAC ALLOGRAFT VASCULOPATHY USING RUBIDIUM-82 CARDIAC POSITRON EMISSION TOMOGRAPHY (2016) (0)
Improved homogeneity of normal MBF using factor analysis with 82Rb PET (2010) (0)
VAGAL HEART RATE MODULATION RELATES INVERSELY TO MYOCARDIAL OXIDATIVE METABOLISM IN HEART FAILURE PATIENTS BOTH WITH AND WITHOUT OBSTRUCTIVE SLEEP APNEA (2010) (0)
Observational Cross-Sectional Study of Inflammatory Markers After Transient Ischemic Attacks, Acute Coronary Syndromes, and Vascular Stroke Events (2020) (0)
Increased cardiac phosphodiesterase-4 levels are observed at 8-10 weeks post-myocardial infarction with (R)-[11C]rolipram PET (2010) (0)
VALIDATION OF [18F]-SODIUM FLUORIDE AS A MARKER OF ACTIVE CALCIFICATION AND HIGH-RISK CAROTID PLAQUE: A SUB-STUDY OF THE CANADIAN ATHEROSCLEROSIS IMAGING NETWORK (CAIN-2) (2015) (0)
Angina pectoris: has the cornerstone of symptomatic coronary artery disease been moved? (2007) (0)
Abstract 20262: In vivo [R)-[11C]Rolipram Positron Emission Tomography Imaging Detects Increased Phosphodiesterase-4 in Normally-Perfused Rat Myocardial Regions 8–12 Weeks Following Myocardial Infarction (2010) (0)
Imaging myocardial phosphodiesterase-4 in rats using (R)-[11C]rolipram and small-animal PET (2009) (0)
Revisiting the evidence for dipyridamole in reducing restenosis: a systematic review and meta-analysis. (2021) (0)
Radiosynthesis of [C-11]methyl-candesartan and its derivative [C-11]TH4 as potential imaging agents for angiotensin II AT1 receptors (2008) (0)
P4697Multi-center clinical evaluation of a precision-controlled rubidium-82 elution system for PET myocardial perfusion imaging (2018) (0)
Left Ventricular Function Recovery After Coronary Revascularization and Medical Therapy: A Systematic Review and Meta-Analysis [version 1; peer review: awaiting peer review] (2021) (0)
P hat is the Prognostic Value of yocardial Perfusion Imaging Using ubidium-82 Positron Emission Tomography ? (2006) (0)
ALTERED MYOCARDIAL GLUCOSE UTILIZATION AND THE REVERSE MISMATCH PATTERN ON 18F-FDG PET DURING THE SUB-ACUTE PHASE FOLLOWING REPERFUSION (2011) (0)
Reproducibility of total perfusion deficit measurements for rubidium-82 PET myocardial perfusion imaging (2015) (0)
ATRIAL ARRHYTHMIAS IN A PROSPECTIVE COHORT OF PATIENTS WITH CLINICALLY MANIFEST CARDIAC SARCOIDOSIS (2020) (0)
IMPACT OF REVASCULARIZATION VERSUS MEDICAL THERAPIES ON LEFT VENTRICULAR FUNCTIONAL RECOVERY IN PATIENTS WITH REDUCED EJECTION FRACTION AND CORONARY ARTERY DISEASE: A META-ANALYSIS & NETWORK META-ANALYSIS (2018) (0)
Left Ventricular Function Recovery After Coronary Revascularization and Medical Therapy: A Systematic Review and Meta-Analysis (2021) (0)
Quantification of phosphodiesterase-4 in the dog heart with (R)-[11C]rolipram PET (2009) (0)
647 Imaging of atherosclerotic vascular lesions in ApoE-/- mice Using [18F]-PyKYNE-c(RGDyK) and PET (2011) (0)
Finding the Road to Rome in Cardiac Allograft Vasculopathy Imaging Surveillance. (2022) (0)
Clinical evaluation of a precision-controlled rubidium-82 elution system for PET myocardial perfusion imaging (2016) (0)
Potential of [11C]meta-hydroxyephedrine for imaging of noradrenergic function in brown adipose tissue and pancreas (2007) (0)
178 Abnormal Neonate Cardiomyocyte Metabolism is Associated with Alterations in Adult Cardiac Metabolism in a Mouse Model of the Arg302gln-prkag2 Cardiac Syndrome (2011) (0)
The right to left ventricular glucose uptake ratio predicts left ventricular function recovery after revascularization in heart failure (2003) (0)
648 Role of FDG-PET in imaging of carotid atherosclerotic plaque (FDG PET substudy of the canadian atherosclerosis imaging network project-II) (2011) (0)
677 Incremental Value of Left Ventricular Function Assessment on Gated Rest/Stress Dipyridamole Technetium 99m SPECT Imaging in the Assessment of Myocardial Viability (2012) (0)
Abstracts of original contributions, ASNC2007, 12th Annual Scientific SessionPoster session III16.23: Normalcy Rate of Computed Tomographic Coronary Angiography (2007) (0)
METABOLIC ACTIVITY OF THE LEFT AND RIGHT ATRIA ARE DIFFERENTIALLY ALTERED ON FDG/PET IMAGING IN ATRIAL FIBRILLATION IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY (2016) (0)
The CREATE Method for Expressing Continuous Outcome Data in Absolute Terms for Use in Patient Treatment Decision Aids (2015) (0)
THE EFFECT OF CONTINUOUS POSITIVE AIRWAY PRESSURE ON RV FUNCTION IN PATIENTS WITH CHF AND OSA: A RANDOMIZED CONTROL TRIAL (2015) (0)
Extent of dipyridamole induced hypoperfusion with 99mTc tetrofosmin and sestamibi SPECT imaging compared to 82Rb PET imaging (2008) (0)
COMPARISON OF THE TWO METHODS FOR THE VASCULAR INFLAMMATION USING FDG PET/CT OF THE AORTA (2016) (0)
B-Type Natriuretic Peptide in Low-Flow Aortic Steno- sis: Relationship to Hemodynamics and Clinical Out- come. Results from the Multicenter TOPAS Study (2006) (0)
Microvascular function, is there a link to myocardial viability: Is this another piece to the puzzle? (2017) (0)
Multi-center performance evaluation of a prototype rubidium-82 elution system for low-dose PET myocardial perfusion imaging (2016) (0)
Comparing Yield and Efficiency of Two Approved Rubidium-82 Generators for PET Imaging (2020) (0)
Findings on Cardiac Computed Tomography Potential Clinical and Economic Consequences of Noncardiac Incidental (2011) (0)
EXPLORING ABNORMALITIES IN PULSATILE ARTERIAL LOAD AS DISTINCT FEATURES OF THE HFPEF SYNDROME IN WOMEN (2023) (0)
279 Right ventricular metabolic imaging in experimental pulmonary artery hypertension (2011) (0)
Model complexity affects test-retest repeatability of myocardial blood flow measurements with 82Rb PET (2014) (0)
Reply to Kawada-N-Terminal Pro B-Type Natriuretic Peptide, High-Sensitivity Cardiac Troponin T and the Extent of Hibernating Myocardium. (2018) (0)
FATTY ACID OXIDATION INHIBITION AS A POTENTIAL NOVEL TREATMENT STRATEGY IN PULMONARY ARTERY HYPERTENSION AND RIGHT HEART FAILURE (2015) (0)
Abstract 12265: Normalization of Renal AT1 Receptor Expression is Observed With Enalapril But Not Diltiazem in a Rat Model of Chronic Kidney Disease (2015) (0)
Elevated Fatty Acid and Glucose Uptake in Right Ventricle in a Sugen 5416/Hypoxia Rat Model of Severe Pulmonary Artery Hypertension (2013) (0)
705 Development of reporter gene PET imaging techniques for long-term assessment of transplanted human circulating progenitor cells (2011) (0)
An Evaluation of Right Ventricular Metabolism in Right Heart Failure Associated with Pulmonary Arterial Hypertension (2014) (0)
854-1 Standards for evaluation of myocardial viability with FDG-positron emission tomography: A comparison of quantitative methods (2004) (0)
SERIAL RUBIDIUM-82 CARDIAC PET IMAGING EARLY POST HEART TRANSPLANT PREDICTS ADVERSE CARDIOVASCULAR OUTCOMES (2019) (0)
Abstract 11959: Cardiac Denervation Appears Before Becoming Myocardial Tissue Fibrosis in Patients With Cardiac Involvement Sarcoidosis and Active Inflammation Using C-11 Hydroxyephedine PET/CT and Cardiac Magnetic Resonance (2014) (0)
Regional Variability of Cardiac Allograft Vasculopathy by Intravascular Ultrasound Assessment. (2020) (0)
Evaluation of [18F]FPyKYNE-losartan as a novel PET tracer for imaging kidney AT1 receptors in rats (2014) (0)
Rebuttal From Drs Birnie, Nery, and Beanlands. (2021) (0)
Stress FDG PET imaging as a new approach to the diagnosis of CAD in women (1997) (0)
A LARGE CANADIAN PERSPECTIVE ON APPROPRIATE USE CRITERIA APPLIED TO NUCLEAR IMAGING (2014) (0)
Rubidium-82 PET versus Thallium-201 SPECT for detection of coronary artery disease in the Alternative Radiopharmaceutical for Myocardial Imaging (ARMI) trial (2014) (0)
Sci—Thur PM: YIS — 08: Comparison of New In-Vivo Measurements for Dosimetry of Rb-82 with Prior Blood Flow Model Predictions (2010) (0)
Effects of Short-Term Continuous Positive Airway Pressure on Myocardial Sympathetic Nerve Function and Energetics in Patients With Heart Failure and Obstructive Sleep Apnea A Randomized Study Imaging (2014) (0)
Diagnosis of unrecognized aortic dissection by hybrid PET/CT rubidium-82 imaging (2021) (0)
Correction (2004) (0)
Abstract 16614: Reduced Glucose Uptake and Increased Glycogen Synthase is Observed Early in a Mouse Model of the Human Arg302Gln-PRKAG2 Cardiac Syndrome (2011) (0)
To the heart of the matter; a valentine’s day to remember (2019) (0)
Hematopoietic stem cell (HSC) redistribution for cardiac repair following acute myocardial infarction (AMI) (2004) (0)
804-4 The relationship between minute ventilation and the rate of CO2elimination reflects the right ventricular oxidative metabolism in heart failure (2004) (0)
13.50 Potential utility of quantitative analysis of 82Rb PET in three vessel coronary artery disease (2001) (0)
Quantification of myocardial blood flow with /sup 13/N-ammonia and /sup 82/Rb PET - OSEM vs. FBP reconstruction (2005) (0)
Does gated 18-F-fluorodeoxyglucose positron emission tomography accurately define cardiac function and better characterize myocardial tissue? (2002) (0)
335 Improving Access to Cardiology Consultation (2012) (0)
Coronary Flow Reserve, Inflammation and Myocardial Strain in the Cardiovascular Inflammation Reduction Trial (CIRT-CFR) (2022) (0)
Abstract 13835: Anti-inflammatory Effect of Rosuvastatin in Patients With HIV Infection: A Randomized Controlled FDG-PET Study (2020) (0)
650 Insulin treatment normalizes noradrenaline levels and cardiac sympathetic innervation in diabetic rats (2011) (0)
Ejection Fraction Coronary Artery Disease, Coronary Atherosclerosis, and Left Ventricular Prognostic Value of 64-Slice Cardiac Computed Tomography: Severity of (2010) (0)
4.15: Diagnostic accuracy and impact of computed tomographic coronary angiography on utilization of invasive coronary angiography (2008) (0)
MP14: Use of conventional cardiac troponin assay for diagnosis of non-ST-elevation myocardial infarction: ‘The Ottawa Troponin Pathway’ (2019) (0)
Automated dynamic motion correction improves repeatability and reproducibility of myocardial blood flow quantification with rubidium-82 PET imaging. (2022) (0)
P Stress Imaging omparison of Treadmill Exercise ersus Dipyridamole Stress With yocardial Perfusion Imaging Using ubidium-82 Positron Emission Tomography (2005) (0)
[18F]-sodium fluoride PET/CT is an imaging-derived biomarker of hydroxyapatite expression in carotid plaque: sub-study of the Canadian Atherosclerosis Imaging Network (CAIN-2) (2015) (0)
236 Decreased β-Adrenoceptor Binding in High-Fat Diet Low-Dose Streptozotocin Rats is Normalized With Similar Efficacy by 2 or 7 Weeks of Insulin-Induced Euglycemia (2012) (0)
A spline model for RV myocardium sampling from cardiac PET images (2013) (0)
High renal retention of [18F]FPyKYNE-Losartan in pigs: Translational work towards imaging AT1 receptors (2014) (0)
GENDER-RELATED DIFFERENCES IN SHORT-TERM REFERRAL RATES TO CATHETERIZATION AFTER NON-INVASIVE CARDIAC IMAGING IN PATIENTS WITHOUT KNOWN CAD: RESULTS FROM THE STUDY OF MYOCARDIAL PERFUSION AND CORONARY ANATOMY IMAGING ROLES IN CAD (SPARC) (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Robert S. B. Beanlands?

Robert S. B. Beanlands is affiliated with the following schools:

Robert S. B. Beanlands's Academic­Influence.com Rankings

Why Is Robert S. B. Beanlands Influential?

Robert S. B. Beanlands's Published Works

Published Works

What Schools Are Affiliated With Robert S. B. Beanlands?

Robert S. B. Beanlands's AcademicInfluence.com Rankings